|
MedPanel Partner, Grey Healthcare, Wins 2001 Agency of the Year and Best Professional Advertisement Awards
Alliance with MedPanel cited as Strategic AdvantageCAMBRIDGE, MA -- MAY 1 2002 -- MedPanel, Inc.'s strategic partner, Grey Healthcare Group, is this year's recipient of two prestigious industry awards: "Agency of the Year" and "Best Professional Ad" from Med Ad News. Med Ad News is read by more than 15,000 pharmaceutical professionals and is considered one of the industry's leading business and marketing publications. The campaign for GlaxoSmithKline's Advair Diskus asthma drug was singled out as best ad.
Grey is the world's fifth largest healthcare communications company. It provides advertising, data-based relationship marketing, medical education, public relations, Web-based initiatives, meeting and symposia management, and contract sales for pharmaceutical and healthcare companies.
Med Ad News noted that Grey reported a 15.1% rise in income from 2000, while their advertising business grew 42%. Growth at the agency was driven by brand launches for Nexium, Advair Diskus and Augmentin ES-600. Other noteworthy client products include Pfizer's Celebrex, Boehringer-Ingelheim's Dulcolax, AstraZeneca's Nexium, and Allergan's Botox.
To support their clients needs, Grey formed a strategic partnership with MedPanel, an online market research firm specializing in thought leader access. MedPanel offers a novel service that brings focus groups and advisory board activities online in a threaded discussion format, providing advantages over traditional market research methodologies. MedPanel's large key opinion leader database and its online masked participation allows hard to reach medical experts to respond according to their own schedules. MedPanel's methodology also allows for geographic dispersity without the travel, encouraging worldwide participation from experts that would otherwise not be willing or able to participate.
With MedPanel's help, Grey Healthcare was able to improve efficiency and scale on projects such as: emotional insight research; branding and positioning; White paper and creative concept testing; clinical trial design research; and online Adboard momentum meetings. MedPanel pre-pitch studies also helped Grey achieve a 57% pitch success rate for new business.
"Through the alliance, Grey Healthcare and MedPanel are providing pharmaceutical companies with improved qualitative research and thought-leader development capabilities," according to Med Ad News report. "MedPanel will uncover what physicians think about a drug pre-launch and post-launch, and Grey will deliver the right marketing tools to leverage those insights," according to Lynn O'Connor Vos, Grey Healthcare president and CEO, as reported by Med Ad News.
Founded in 1999, MedPanel works with pharmaceutical, biotechnology and medical device companies and the marketing, communications agencies, and financial groups who support them. Clients include Aventis, Bayer AG, Boston Scientific Corporation, GlaxoSmithKline, GelTex Pharmaceuticals, Hollister Inc., Eli Lilly and Company, Millennium Pharmaceuticals, and Pfizer Inc.
Contact: Erin Sheehan 617-661-8080 x29
www.MedPanel.com